top of page
Executive Spotlights

Inari Acquires LimFlow, a Limb-Saving Device Manufacturer, in a $415M Deal

Irvine, CA, November 3, 2023 (Finance.yahoo) -- Inari Medical will acquire LimFlow, a company specializing in a device for chronic limb-threatening blood flow loss, for $250 million in cash along with potential milestone payments, in a deal worth $415 million. LimFlow's technology aims to restore oxygenated blood flow to the foot through veins, bypassing blocked leg arteries, in individuals with chronic limb-threatening ischemia (CLTI). This treatment is designed for patients at risk of amputation after exhausting other treatment options.


Read full article here.

Recent Posts

See All

Ophirex Appoints Jeremy Gowler as CEO

Corte Madera, CA, July 15, 2024 (Business Wire) -- Ophirex, Inc., a company focused on developing an oral treatment for snakebite victims, has appointed Jeremy Gowler as CEO. Prior to joining Ophire

Life Science Headlines
bottom of page